Publications by authors named "Emily Hull-Ryde"

Claim this Profile
F
Functional role of the ER stress transducer IRE1α in CF airway epithelial inflammation.
Carla M P Ribeiro, Emily A Hull-Ryde

Curr Opin Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IRE1α Is a Therapeutic Target for Cystic Fibrosis Airway Inflammation.
Emily A Hull-Ryde, John T Minges, Mary E B Martino, Takafumi Kato, Jacqueline L Norris-Drouin

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.
Gang Chen, Carla M P Ribeiro, Ling Sun, Kenichi Okuda, Takafumi Kato, Emily A Hull-Ryde

Am J Respir Crit Care Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Cosalane as an Inhibitor of Human and Murine CC-Chemokine Receptor 7 Signaling via a High-Throughput Screen.
Emily A Hull-Ryde, Melissa A Porter, Kenneth A Fowler, Dmitri Kireev, Kelin Li

SLAS Discov· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Instrument Quality Control.
Chatura Jayakody, Emily A Hull-Ryde

Methods Mol Biol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of small molecule inhibitors that block the rhoptry kinase ROP18.
Catherine Simpson, Nathaniel G Jones, Emily A Hull-Ryde, Dmitri Kireev, Michael Stashko

ACS Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tackling reproducibility in academic preclinical drug discovery.
Stephen V Frye, Michelle R Arkin, Cheryl H Arrowsmith, P Jeffrey Conn, Marcie A Glicksman, Emily A Hull-Ryde

Nat Rev Drug Discov· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filtration improves the performance of a high-throughput screen for anti-mycobacterial compounds.
Nancy Cheng, Melissa A Porter, Lloyd W Frick, Yvonne Nguyen, Jennifer D Hayden, Emily A Hull-Ryde

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C.
Brittany D Wright, Catherine Simpson, Michael Stashko, Dmitri Kireev, Emily A Hull-Ryde

J Biomol Screen· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.
Nancy Cheng, Sook-Kyung Lee, P Scott Donover, Mel Reichman, Celia A Schiffer, Emily A Hull-Ryde

J Lab Autom· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo.
Sandra Christoph, Deborah Deryckere, Jennifer Schlegel, J Kimble Frazer, Lance A Batchelor, Emily A Hull-Ryde

Mol Cancer Ther· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid.
Sook-Kyung Lee, Nancy Cheng, Emily Hull-Ryde, Marc Potempa, Celia A Schiffer

Biochemistry· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice.
Ilia Korboukh, Emily A Hull-Ryde, Joseph E Rittiner, Amarjit S Randhawa, Jennifer Coleman

J Med Chem· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMP is an adenosine A1 receptor agonist.
Joseph E Rittiner, Ilia Korboukh, Emily A Hull-Ryde, Jian Jin, William P Janzen

J Biol Chem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.
Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, Jeff E Cobb, Jon L Collins, Emily A Hull-Ryde

Biochemistry· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis